Related Experiment Video
Updated: Jun 2, 2026

Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes
Published on: February 18, 2020
Design and development of Amphotericin B bearing polycaprolactone microparticles for macrophage targeting
Pankaj Singh1, Amit Gupta, Anil Jaiswal
1Pharmaceutics Division, Central Drug Research Institute, (Council of Scientific and Industrial Research, India), P.O. Box 173, M. G. Marg, Lucknow 226001, India.
Abstract:
Antileishmanial efficacy of Amphotericin B bearing polycaprolactone (PCL) microparticles was investigated. The microparticles were prepared, optimized and subjected to in vitro characterization for shape (spherically structured), particle size (9.83 +/- 1.12 microm), entrapment efficiency (43.54 +/- 3.98%) and in vitro drug release. The study revealed that PCL microparticles bearing Amphotericin B can be effectively used to target leishmanial parasites residing in macrophages.
Related Concept Videos
Antifungal Agents
Site-Targeted Drug Delivery Systems: Polymeric Carriers
